Purpose: To investigate the efficacy and safety of the retention ring-assisted continuous application of 0.1% riboflavin in pulsed-light accelerated corneal collagen cross-linking on the progression of keratoconus.
Methods: The medical records of 20 eyes of 18 patients with progressive keratoconus who received collagen cross-linking at Seoul National University Hospital were retrospectively reviewed. Isotonic 0.1% riboflavin was continuously applied for 10 minutes using an 8.0-mm retention ring before the irradiation and accelerated cross-linking was applied with 30-mW pulsed-ultraviolet light at a wavelength 365 nm for eight minutes (1 second on/1 second off; 30 mW/cm2, cumulative dose of 7.2J/cm2) without further intermittent application of riboflavin. Visual acuity, refractive error, topographic index, corneal thickness, and endothelial cell density were evaluated before the operation and at 1, 3, 6, and 12 months.
Results: The best corrected visual acuity in logMAR improved from preoperative 0.43 to 0.18 in 12 months. Maximum keratometry decreased from 51.8 D to 50.4 D at six months (p = 0.015) and 50.3 D at 12 months (p < 0.0001). Astigmatism decreased from preoperative 5.5 D to 4.2 D at 12 months (p < 0.0001). Thinnest corneal thickness decreased at three and six months but recovered in 12 months (p > 0.05). Endothelial cell density decreased at one month (p = 0.02) but gradually recovered in 12 months (p > 0.05).
Conclusions: Continuous application of riboflavin using a retention ring for 10 minutes in an accelerated pulsed-light collagen cross-linking seems to be safe and effective for halting the progression of the keratoconus.